🇺🇸 FDA
Patent

US 9511121

Method for delivering exenatide to a patient in need thereof

granted A61KA61K31/155A61K38/26

Quick answer

US patent 9511121 (Method for delivering exenatide to a patient in need thereof) held by Rani Therapeutics, LLC expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/155, A61K38/26, A61K38/28, A61K45/06